Showing results (61-70 of 197) with videos related to

Sort By:
Pageof 20
Respiratory Medicine|December 14, 2004
Inflammatory parameters after pleurodesis in recurrent malignant pleural effusions and their predictive valueValiant Ukale, Veronica Agrenius, Olle Widström, et al.
Lung Cancer (Amsterdam, Netherlands)|May 29, 2004
Pleurodesis in recurrent pleural effusions: a randomized comparison of a classical and a currently popular drugValiant Ukale, Veronica Agrenius, Gunnar Hillerdal, et al.
Acta Oncologica (Stockholm, Sweden)|August 25, 2016
Lung cancer among native and foreign-born Swedes: histopathology, treatment, and survivalHirsh Koyi, Gunnar Hillerdal, Olov Andersson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2006
Progression-free survival rate as primary end point for phase II cancer clinical trials: application to mesothelioma--The EORTC Lung Cancer GroupJulie Francart, Catherine Legrand, Richard Sylvester, et al.
Respiratory Medicine|July 4, 2021
Mesothelioma in immigrants from Turkey: Genes have a minor roleSelma Metintas, Muzaffer Metintas, Guntulu Ak, et al.
The European Respiratory Journal|December 23, 2017
Exhaled breath to screen for malignant pleural mesothelioma: a validation studyKevin Lamote, Matthijs Vynck, Olivier Thas, et al.
Journal of Breath Research|September 27, 2016
Detection of malignant pleural mesothelioma in exhaled breath by multicapillary column/ion mobility spectrometry (MCC/IMS)Kevin Lamote, Matthijs Vynck, Joris Van Cleemput, et al.
Current Opinion in Oncology|November 6, 2019
Local treatment of stage IIIA-N2 nonsmall cell lung cancer: surgery and/or radiotherapyJan P Van Meerbeeck, Christel De Pooter, Jo Raskin, et al.
The Clinical Respiratory Journal|March 20, 2010
Treatment of malignant pleural mesothelioma with liposomized doxorubicine: prolonged time to progression and good survival. A Nordic studyGunnar Hillerdal, Jens Benn Sorensen, Stein Sundström, et al.
The European Respiratory Journal|May 18, 2013
Slow-growing lung cancer as an emerging entity: from screening to clinical managementMaurizio Infante, Thierry Berghmans, Marjolein A Heuvelmans, et al.
Pageof 20